Ian R. Baxendale

14.4k total citations · 4 hit papers
208 papers, 11.8k citations indexed

About

Ian R. Baxendale is a scholar working on Organic Chemistry, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ian R. Baxendale has authored 208 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Organic Chemistry, 115 papers in Biomedical Engineering and 69 papers in Molecular Biology. Recurrent topics in Ian R. Baxendale's work include Innovative Microfluidic and Catalytic Techniques Innovation (113 papers), Chemical Synthesis and Analysis (49 papers) and Microfluidic and Capillary Electrophoresis Applications (34 papers). Ian R. Baxendale is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (113 papers), Chemical Synthesis and Analysis (49 papers) and Microfluidic and Capillary Electrophoresis Applications (34 papers). Ian R. Baxendale collaborates with scholars based in United Kingdom, United States and Italy. Ian R. Baxendale's co-authors include Steven V. Ley, Marcus Baumann, Nikzad Nikbin, Matthew O’Brien, Christopher D. Smith, Carl J. Mallia, Geoffrey K. Tranmer, Anastasios Polyzos, Laura K. Smith and Charlotte Griffiths-Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ian R. Baxendale

200 papers receiving 11.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles

2013 679 citations Marcus Baumann, Ian R. Baxendale Beilstein Journal of Organic Chemistry profile →
Multi-step organic synthesis using solid-supported reagents and scavengers: a new paradigm in chemical library generation

2000 592 citations Steven V. Ley, Ian R. Baxendale et al. profile →
An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals

2011 473 citations Marcus Baumann, Ian R. Baxendale et al. Beilstein Journal of Organic Chemistry profile →
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule

2012 452 citations Benedict C. S. Cross, Peter J. Bond et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian R. Baxendale United Kingdom	59	7.1k	6.1k	3.2k	1.4k	1.1k	208	11.8k
Andreas Kirschning Germany	52	6.7k 0.9×	3.2k 0.5×	4.0k 1.2×	1.1k 0.8×	1.1k 1.0×	365	10.9k
Manfred T. Reetz Germany	67	4.8k 0.7×	2.6k 0.4×	11.2k 3.5×	2.2k 1.6×	1.9k 1.8×	208	15.7k
Nicholas J. Turner United Kingdom	76	7.5k 1.1×	4.1k 0.7×	15.6k 4.9×	3.6k 2.6×	1.8k 1.7×	439	21.2k
Harald Gröger Germany	49	6.0k 0.8×	1.7k 0.3×	5.6k 1.7×	2.7k 2.0×	1.0k 0.9×	281	10.5k
Albert S. C. Chan Hong Kong	69	11.9k 1.7×	1.9k 0.3×	3.6k 1.1×	7.4k 5.3×	1.0k 0.9×	403	15.9k
Jun‐ichi Yoshida Japan	74	14.9k 2.1×	6.3k 1.0×	3.4k 1.1×	1.9k 1.4×	1.9k 1.8×	461	20.4k
Andreas S. Bommarius United States	46	1.2k 0.2×	2.4k 0.4×	4.8k 1.5×	580 0.4×	1.2k 1.1×	162	7.6k
Hironao Sajiki Japan	53	5.5k 0.8×	1.2k 0.2×	1.5k 0.5×	3.1k 2.2×	1.1k 1.0×	318	8.4k
Xiao‐Qi Yu China	62	6.1k 0.9×	2.2k 0.4×	5.3k 1.7×	1.5k 1.1×	5.1k 4.8×	563	16.3k
Chao Wang China	49	2.8k 0.4×	1.6k 0.3×	1.8k 0.6×	329 0.2×	2.9k 2.7×	189	7.7k

Countries citing papers authored by Ian R. Baxendale

Since Specialization

Citations

This map shows the geographic impact of Ian R. Baxendale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Baxendale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Baxendale more than expected).

Fields of papers citing papers by Ian R. Baxendale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Baxendale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Baxendale. The network helps show where Ian R. Baxendale may publish in the future.

Co-authorship network of co-authors of Ian R. Baxendale

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Baxendale. A scholar is included among the top collaborators of Ian R. Baxendale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Baxendale. Ian R. Baxendale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tinivella, Annachiara, Paola Orlandi, Ian R. Baxendale, et al.. (2023). Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase. ACS Pharmacology & Translational Science. 6(12). 1870–1883. 3 indexed citations

Dombrowski, Amanda W., et al.. (2019). Photochemical Flow Synthesis of 3‐Hydroxyazetidines. ChemPhotoChem. 3(12). 1212–1218. 18 indexed citations

Baxendale, Ian R., et al.. (2019). Synthesis of new derivatives of boehmeriasin A and their biological evaluation in liver cancer. European Journal of Medicinal Chemistry. 166. 243–255. 8 indexed citations

Kitching, Matthew O., et al.. (2017). Flow‐Assisted Synthesis: A Key Fragment of SR 142948A. European Journal of Organic Chemistry. 2017(44). 6540–6553. 23 indexed citations

Mallia, Carl J., et al.. (2016). Flow carbonylation of sterically hindered ortho-substituted iodoarenes. Beilstein Journal of Organic Chemistry. 12. 1503–1511. 15 indexed citations

Stanetty, Christian & Ian R. Baxendale. (2015). Large‐Scale Synthesis of Crystalline 1,2,3,4,6,7‐Hexa‐O‐acetyl‐L‐glycero‐α‐D‐manno‐heptopyranose. European Journal of Organic Chemistry. 2015(12). 2718–2726. 22 indexed citations

Christodoulou, Michael S., Francesco Calogero, Marcus Baumann, et al.. (2015). Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2. European Journal of Medicinal Chemistry. 92. 766–775. 31 indexed citations

Mallia, Carl J. & Ian R. Baxendale. (2015). The Use of Gases in Flow Synthesis. Organic Process Research & Development. 20(2). 327–360. 299 indexed citations

Baxendale, Ian R., Richard D. Braatz, B.K. Hodnett, et al.. (2014). Achieving Continuous Manufacturing: Technologies and Approaches for Synthesis, Workup, and Isolation of Drug Substance May 20–21, 2014 Continuous Manufacturing Symposium. Journal of Pharmaceutical Sciences. 104(3). 781–791. 120 indexed citations

10.

Baxendale, Ian R., et al.. (2013). Flow chemistry approaches directed at improving chemical synthesis. Green Processing and Synthesis. 2(3). 211–230. 29 indexed citations

11.

Cross, Benedict C. S., Peter J. Bond, Paweł Sadowski, et al.. (2012). The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. 9 indexed citations

12.

Ron, David, et al.. (2012). Establishing a Flow Process to Coumarin‐8‐Carbaldehydes as Important Synthetic Scaffolds. Chemistry - A European Journal. 18(32). 9901–9910. 39 indexed citations

13.

Deadman, Benjamin J., Mark D. Hopkin, Ian R. Baxendale, & Steven V. Ley. (2012). The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Organic & Biomolecular Chemistry. 11(11). 1766–1800. 46 indexed citations

14.

Hopkin, Mark D., Ian R. Baxendale, & Steven V. Ley. (2011). The Lab of the Future - The importance of remote monitoring and control. Durham Research Online (Durham University). 1 indexed citations

15.

Browne, Duncan L., et al.. (2011). Continuous Flow Processing of Slurries: Evaluation of an Agitated Cell Reactor. Organic Process Research & Development. 15(3). 693–697. 122 indexed citations

16.

Hodgkinson, James T., Warren R. J. D. Galloway, Ian R. Baxendale, et al.. (2010). Microwave and flow syntheses of Pseudomonasquinolone signal (PQS) and analogues. Organic & Biomolecular Chemistry. 9(1). 57–61. 47 indexed citations

17.

Palmieri, Alessandro, Steven V. Ley, Anastasios Polyzos, Mark Ladlow, & Ian R. Baxendale. (2009). Continuous flow based catch and release protocol for the synthesis of α-ketoesters. Beilstein Journal of Organic Chemistry. 5. 23–23. 34 indexed citations

18.

Ley, Steven V., Ian R. Baxendale, Charlotte Griffiths-Jones, & Geoffrey K. Tranmer. (2006). Preparation of the Neolignan Natural Product Grossamide by a Continuous-Flow Process. Synlett. 2006(3). 427–430. 29 indexed citations

19.

Baxendale, Ian R., Steven V. Ley, & Claudia Piutti. (2002). Total Synthesis of the Amaryllidaceae Alkaloid (+)-Plicamine and Its Unnatural Enantiomer by Using Solid-Supported Reagents and Scavengers in a Multistep Sequence of Reactions We gratefully acknowledge financial support from Pfizer Central Research for a Postdoctoral Fellowship (to I.R.B.), the BP endowment and the Novartis Research Fellowship (to S.V.L.), and Pharmacia & Upjohn (to C.P.).. Angewandte Chemie International Edition. 41(12). 2194–2194. 119 indexed citations

20.

Baxendale, Ian R. & Steven V. Ley. (2000). Polymer-supported reagents for multi-step organic synthesis: application to the synthesis of sildenafil. Bioorganic & Medicinal Chemistry Letters. 10(17). 1983–1986. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact